CYX Calyx Ventures Inc

Calyx Bio-Ventures Inc. (TSX VENTURE:CYX) ("Calyx") is pleased to announce that
is has entered into a letter of intent to acquire Cannigistics Agri-Solutions
Corp. ("Cannigistics"), a company focused on bringing sophisticated, versatile,
and flexible technology solutions to advanced indoor agriculture.


Cannigistics is developing an efficient application framework that can help
growers and agri-facility managers optimize operational efficiency, regulatory
compliance, and production results. Cannigistics is presently designing an
enterprise software platform tailored to the medical marijuana industry. With
the significant reporting requirements of Health Canada and other global
agencies as the medical marijuana industry continues to see legalization and
rapidly changing regulation, together with the need for tightly controlled
growing conditions, it is essential for enterprise software to track, manage,
and enhance grower practices in this fast growing industry. 


As the medical marijuana industry emerges, new and sophisticated information
requirements are becoming apparent for maximizing yield, facility management,
integrated security, packaging, labeling and distribution, logistics and
tracking. Additionally, the compliance and record keeping requirements are
unprecedented and vital to success in the medical marijuana sector. Cannigistics
is positioning to be the industry leader in agri-software solutions. 


"With Calyx's extensive background in biosciences and agriculture innovation, it
is the ideal company for us to be part of as we launch a scalable enterprise
solution for indoor agriculture, specifically targeting the medical marijuana
industry" said Roger Forde, President and CEO of Cannigistics. "Our proprietary,
easy-to-use product offering will allow growers to obtain the metrics they
require to maximize profits and streamline compliance. The legal marijuana
supply industry is seeing substantial investment, and we are focused on becoming
the dominant solutions provider to this industry, which is expected to grow to
$1.3 billion per year in just Canada alone."


Under the terms of the acquisition, Calyx will acquire all of the issued and
outstanding shares of Cannigistics in exchange for 9,000,000 common shares of
Calyx. The acquisition remains subject to the fulfillment of certain conditions,
including the execution of definitive agreements and the approval of the TSX
Venture Exchange.


About Calyx

Calyx Bio-Ventures Inc. (TSX VENTURE:CYX) is an agricultural technology company
focused on early stage agriculture ventures. Calyx owns a portfolio of
proprietary intellectual property with applications in crop enhancement. In
addition to Calyx's shareholding in Agrisoma Biosciences Inc., a company which
is producing a non-food energy feedstock crop for biofuel production, Calyx is
pursuing other agri-pharmaceutical and agri-tech opportunities, including
opportunities in the MMPR (Marijuana for Medical Purposes Regulations) space.
For further information about Calyx, please visit www.calyxbio.com.


About Cannigistics

Cannigistics is presently developing a sophisticated, versatile, and flexible
enterprise software platform tailored to advanced indoor agriculture, and
specifically the medical marijuana industry. The company is positioning to be
the industry leader in agri-software solutions and is designing an efficient
application framework that can help growers and agri-facility managers optimize
operational efficiency, regulatory compliance, and production results. For
further information about Cannigistics, please visit www.cannigisticscorp.com.


Forward-Looking Statements: This document contains certain forward-looking
statements concerning Calyx, as well as other expectations, plans, goals,
objectives, information or statements about future events, conditions, or
performance that may constitute "forward-looking statements" or "forward-looking
information" under applicable securities legislation. Such statements or
information involve substantial known and unknown risks and uncertainties,
certain of which are beyond Calyx's control. 


Such forward-looking statements or information are based on a number of
assumptions, which may prove to be incorrect.


Although Calyx believes that the expectations reflected in such forward-looking
statements or information are reasonable, undue reliance should not be placed on
forward-looking statements because Calyx can give no assurance that such
expectations will prove to be correct. Forward-looking statements or information
are based on current expectations, estimates and projections that involve a
number of risks and uncertainties which could cause actual results to differ
materially from those anticipated by Calyx and described in the forward-looking
statements or information.


The forward-looking statements or information contained in this news release are
made as of the date hereof and Calyx undertakes no obligation to update publicly
or revise any forward-looking statements or information, whether as a result of
new information, future events or otherwise unless so required by applicable
securities laws or the TSX Venture Exchange. The forward-looking statements or
information contained in this news release are expressly qualified by this
cautionary statement.


Neither the TSX Venture Exchange nor its Regulation Services Provider (as that
term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release.


FOR FURTHER INFORMATION PLEASE CONTACT: 
Calyx Bio-Ventures
Don Konantz
President & CEO
(604) 649-5961
dkonantz@calyxbio.com
www.calyxbio.com


Cannigistics Agri-Solutions
Roger Forde
President & CEO
(778) 331-5156
rforde@cannigisticscorp.com
www.cannigisticscorp.com

Calyx Ventures (TSXV:CYX)
Historical Stock Chart
From Mar 2024 to Apr 2024

Calyx Ventures (TSXV:CYX)
Historical Stock Chart
From Apr 2023 to Apr 2024